These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 23274844)
1. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study. Kaplan H; Malmgren J; De Roos AJ Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844 [TBL] [Abstract][Full Text] [Related]
2. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors. Kaplan HG; Malmgren JA; Li CI; Calip GS Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034 [TBL] [Abstract][Full Text] [Related]
3. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005. Kaplan HG; Malmgren JA; Atwood MK BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006 [TBL] [Abstract][Full Text] [Related]
4. Leukemia incidence following primary breast carcinoma treatment. Kaplan HG; Malmgren JA; Atwood M Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478 [TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714 [TBL] [Abstract][Full Text] [Related]
6. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192 [TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members. Padmanabhan A; Baker JA; Zirpoli G; Sait SN; Ford LA; Moysich KB; Baer MR Leuk Res; 2008 Dec; 32(12):1820-3. PubMed ID: 18468682 [TBL] [Abstract][Full Text] [Related]
9. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience. Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450 [TBL] [Abstract][Full Text] [Related]
10. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278 [TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study. Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212 [TBL] [Abstract][Full Text] [Related]
12. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries. Polednak AP J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study. Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885 [TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. Patt DA; Duan Z; Fang S; Hortobagyi GN; Giordano SH J Clin Oncol; 2007 Sep; 25(25):3871-6. PubMed ID: 17664457 [TBL] [Abstract][Full Text] [Related]
15. Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation. Radivoyevitch T; Sachs RK; Gale RP; Molenaar RJ; Brenner DJ; Hill BT; Kalaycio ME; Carraway HE; Mukherjee S; Sekeres MA; Maciejewski JP Leukemia; 2016 Feb; 30(2):285-94. PubMed ID: 26460209 [TBL] [Abstract][Full Text] [Related]
16. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States. Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525 [TBL] [Abstract][Full Text] [Related]
17. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650 [TBL] [Abstract][Full Text] [Related]